investor.alderbio.com
Our Mission - Alder BiopharmaceuticalsThe Investor Relations website contains information about Alder Biopharmaceuticals business for stockholders, potential investors, and financial analysts.
http://investor.alderbio.com/
The Investor Relations website contains information about Alder Biopharmaceuticals business for stockholders, potential investors, and financial analysts.
http://investor.alderbio.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
1 seconds
16x16
PAGES IN
THIS WEBSITE
15
SSL
EXTERNAL LINKS
61
SITE IP
206.200.251.19
LOAD TIME
1.047 sec
SCORE
6.2
Our Mission - Alder Biopharmaceuticals | investor.alderbio.com Reviews
https://investor.alderbio.com
The Investor Relations website contains information about Alder Biopharmaceuticals business for stockholders, potential investors, and financial analysts.
investor.alderbio.com
SEC Filings - Alder Biopharmaceuticals
http://investor.alderbio.com/sec.cfm
Annual Reports and Proxies. Annual Reports and Proxies. All Filings (excluding Section 16). Oct 27, 2016. File is in Briefcase. Oct 27, 2016. File is in Briefcase. Oct 19, 2016. Litton, mark james. File is in Briefcase. Oct 11, 2016. File is in Briefcase. Oct 11, 2016. File is in Briefcase. Oct 7, 2016. File is in Briefcase. Oct 5, 2016. Smith, jeffrey t l. File is in Briefcase. Oct 5, 2016. Schatzman, randall c. File is in Briefcase. Oct 5, 2016. Latham, john a. File is in Briefcase. Sep 8, 2016.
Committee Composition - Alder Biopharmaceuticals
http://investor.alderbio.com/committees.cfm
Annual Reports and Proxies. Annual Reports and Proxies. Stephen M. Dow. Member of the Audit Committee. Chair of the Nominating and Corporate Governance Committee. Member of the Compensation Committee. Chair of the Audit Committee. A Bruce Montgomery, M.D. Member of the Nominating and Corporate Governance Committee. Deepa R. Pakianathan, Ph.D. Member of the Compensation Committee. Heather Preston, M.D. Member of the Audit Committee. Member of the Nominating and Corporate Governance Committee.
Stock Information - Alder Biopharmaceuticals
http://investor.alderbio.com/stockquote.cfm
Annual Reports and Proxies. Annual Reports and Proxies. 4:00 PM ET on Nov 2, 2016. Sign up for email alerts. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by NASDAQ OMX, both third party services, and Alder Biopharmaceuticals does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. Annual Reports and Proxies.
Analyst Coverage - Alder Biopharmaceuticals
http://investor.alderbio.com/analysts.cfm
Annual Reports and Proxies. Annual Reports and Proxies. Alder Biopharmaceuticals is covered by the following analysts. Vamil Divan, MD. Brian Abrahams, MD. Joseph P. Schwartz. Charles C. Duncan, PhD. Jim Birchenough, MD. 2016 Alder Biopharmaceuticals Inc. Annual Reports and Proxies.
Historic Stock Lookup - Alder Biopharmaceuticals
http://investor.alderbio.com/stocklookup.cfm
Annual Reports and Proxies. Annual Reports and Proxies. Adjusted historic prices for the week of October 31, 2016. Oct 31, 2016. Nov 1, 2016. Nov 2, 2016. Year End Stock Prices. 2016 Alder Biopharmaceuticals Inc. Annual Reports and Proxies.
TOTAL PAGES IN THIS WEBSITE
15
Overview - Alder Biopharmaceuticals
http://www.alderbio.com/about
Events & Presentations. Financials & Filings. Alder BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. 2016 Alder BioPharmaceuticals Inc. Events & Presentations. Financials & Filings.
Careers - Alder Biopharmaceuticals
http://www.alderbio.com/careers
Events & Presentations. Financials & Filings. At Alder, we seek talented contributors who thrive in a high-energy team environment and want to make a real and lasting impact in the field of antibody therapeutics. Alder teams are creative, collaborative, open, committeed–and central to the success of this company and its mission. If this is the kind of company you want to work for, we want to hear from you. Send us your resume. No unsolicited resumes from recruiters, please). In the Pacific Northwest.
Current Openings - Alder Biopharmaceuticals
http://www.alderbio.com/careers/current-openings
Events & Presentations. Financials & Filings. Corporate Counsel, Contracts. Specific Responsibilities will include:. Leads the drafting, review, interpretation, negotiation and execution of all routine agreements, such as confidentiality, material transfer, consulting, services, clinical trial, manufacturing, license and vendor agreements, while appropriately engaging the General Counsel for complicated terms or negotiations. Efficiently coordinates exchange of contract drafts and negotiation sessions.
Pipeline - Alder Biopharmaceuticals
http://www.alderbio.com/therapeutics/pipeline
Events & Presentations. Financials & Filings. Numerous anticipated clinical milestones. Our pipeline includes three internally discovered humanized monoclonal antibodies (including one preclinical monoclonal antibody), as well as preclinical programs targeting additional indications that are in the discovery phase. The primary and key secondary efficacy endpoints were met in an ongoing double blind, randomized, placebo-controlled Phase 2b of ALD403 in patients with 15 or more headache days a month, at le...
Board of Directors - Alder Biopharmaceuticals
http://www.alderbio.com/about/board-of-directors
Events & Presentations. Financials & Filings. Stephen M. Dow. Mr Dow has served as a member of our board of directors since April 2005 and as our chairperson since September 2005. Mr Carter has served as a member of our board of directors since September 2015. Mr Cleveland has served as a member of our board of directors since August 2015. A Bruce Montgomery, M.D. Dr Montgomery has served as a member of our board of directors since October 2010. Deepa R. Pakianathan, Ph.D. Heather Preston, M.D.
Mission - Alder Biopharmaceuticals
http://www.alderbio.com/about/mission
Events & Presentations. Financials & Filings. Alder’s mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. The work being done at Alder today will potentially help those who suffer from migraine, autoimmune diseases, and inflammatory diseases. 2016 Alder BioPharmaceuticals Inc. Events & Presentations. Financials & Filings.
Press Releases - Alder Biopharmaceuticals
http://www.alderbio.com/news/press-releases
Events & Presentations. Financials & Filings. Alder BioPharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference. Alder BioPharmaceuticals Reports Third Quarter 2015 Financial and Operating Results. Alder BioPharmaceuticals to Present at the Credit Suisse 24th Annual Healthcare Conference. Alder BioPharmaceuticals to Host Conference Call to Discuss Third Quarter Financial and Operating Results. Alder BioPharmaceuticals Appoints Paul R. Carter to Board of Directors. Alder BioPharmace...
Leadership Team - Alder Biopharmaceuticals
http://www.alderbio.com/about/management-team
Events & Presentations. Financials & Filings. Randall C. Schatzman, Ph.D. President and Chief Executive Officer. Dr Schatzman has served as our President, Chief Executive Officer and director since he co-founded the company, which commenced operations in January 2004. John A. Latham, Ph.D. Dr Latham has served as our Chief Scientific Officer since co-founding Alder BioPharmaceuticals in January 2004. Mark J. Litton, Ph.D., MBA. Chief Business Officer and Treasurer. Senior Vice President, Finance.
Scientific Advisors - Alder Biopharmaceuticals
http://www.alderbio.com/about/advisory-board
Events & Presentations. Financials & Filings. Messoud Ashina M.D., Ph.D. Dr Ashina is the Associate Professor at the Department of Neurology and Danish Headache Center, Glostrup Hospital, University of Copenhagen. David W. Dodick, M.D., FRCP, FACP. Dr Dodick is professor of neurology at Mayo Clinic College of Medicine and Consultant in Neurology at Mayo Clinic in Scottsdale, Arizona. The Neurologist and Postgraduate Medicine. Peter Goadsby, M.B., Ph.D. Richard Lipton, M.D. Dr Lipton is currently a Profes...
TOTAL LINKS TO THIS WEBSITE
61
Home Page
Airware Labs Corporation AIRW. Regulatory Reports and Filings. Break Through Breathing Technology. Airware interview with the American Urban Radio Networks. A Harnessing Plant-Based Essential Oils To Clean Up The Oxygen Supply. AIR SLEEP/SNORE got a shout out on ABC 10 Miami as a drug-free solution to improve sleep! Study finds cognitive therapy can improve sleep without use of medication. Airware Labs Featured on Drug Topics. AirWare Featured on NBC affiliate in Sacramento. Airware Labs Featured on.
AIS Investor Relations
AIS ช ว ตในแบบค ณ. Result Announcement 2Q15: 3 Aug 2015. No of shares (million). No1 Thailand mobile operators, both in terms of subscribers and revenue market shares. The largest network coverage with over 15.000 cell sites nationwide. Successfully developing three distinctive brands targeting different customer profile. Maintain market share leader both in city and rural areas.Strong dividend payment with low debt profile. 2Q15 results : 2Q15 Financial result is now available. View or Pay my bill online.
Advanced Information Technology Public Company Limited: IR Home
Keep up to date with the AIT's investors news. The investment in Campana Company. Resolutions of AGM 1/2017. Publication of the Annual General Shareholders Meeting (AGM) No.1/2017 invitation and Annual Report both in Thai. SET Opportunity Day Q4/2016: 16 Mar 2017. Opportunity Day is at 14:10 to 15:10, Meeting Room 603 , Stock Exchange of Thailand. Invitation to the Annual General Meeting 1/2017. Corporate Governance Year 2014. Annual General Meeting 1/2017. Annual Report Year 2016. 66 (0) 2275 9400.
Investor Relations - Company Profile - Arthur J. Gallagher & Co.
Skip to main content. Skip to main Navigation. Arthur J. Gallagher and Co. Arthur J. Gallagher, Inc. Commercial Insurance and Risk Management. Alternative Risk and Captives. Commercial Surety and Bonds. Private Client and Personal Insurance. Trade Credit and Political Risk. Benefits and HR Consulting. Human Resources and Compensation. Institutional Investment and Fiduciary Services. Multinational Benefits and Human Resources. Claims Management and Third-Party Administration. Energy, Oil and Gas. Primary ...
Investors | Investors | Alaska Airlines
Skip to main content. Stock Quote and Chart. Annual Reports and Proxy. Annual Meeting and Proxy. Relax on a Beach. Board Room Airport Lounge. Earn and Use Miles. Buy and Share Miles. Profile and Tier Status. Stock quote and chart. Annual reports and proxy. Annual meeting and proxy. Alaska Receives DOJ Clearance. December 6, 2016. Alaska to acquire Virgin America. Alaska Acquires Virgin America Investor Deck. Alaska Air Group Reports December 2016 and Full-Year Operational Results. 160; 1.80.
Our Mission - Alder Biopharmaceuticals
Annual Reports and Proxies. Annual Reports and Proxies. Alder is a clinical-stage biopharmaceutical company that discovers, develops, and seeks to commercialize therapeutic antibodies with the potential to transform current treatment paradigms in meaningful ways. The work being done at Alder today will potentially help those who suffer from migraine, autoimmune diseases, and inflammatory diseases. 2015 Alder Biopharmaceuticals Inc. Annual Reports and Proxies.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@investor.alere.com. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
Aleris - InvestorRoom - Aleris Overview
Aleris is a global leader in the production and sale of aluminum rolled products. From its headquarters in Cleveland, Ohio, Aleris operates 13 production facilities throughout the United States, Europe, and Asia, providing products and services to customers in a variety of industries. Mar 19, 2018. Aleris Reports Fourth Quarter and Full Year 2017 Results. Mar 14, 2018. Aleris to Announce Fourth Quarter and Full Year 2017 Financial Results on March 19. Mar 5, 2018. Monday, March 19, 2018. 1 216 910 3229.
Align Technology, Inc. - Investors
Align Technology’s market opportunity and value proposition are strong and we are continuing to execute our strategies to increase adoption and utilization of our products and services worldwide. Stock Quote and Chart. View all ». Jan 30, 2018 at 4:30 PM ET. Fourth Quarter 2017 Financial Results Conference. View all ». Mar 6, 2018. Align Technology to Host Investor Day on May 23, 2018. Mar 5, 2018. Kevin J. Dallas Joins Align Technology Board of Directors. Feb 28, 2018. Feb 8, 2018. Feb 8, 2018.
Investor Relations | Alimera Sciences
Skip to main navigation. Diabetic Macular Edema (DME). Retinal Vein Occlusion (RVO). Age-Related Macular Degeneration (AMD). Alimera Sciences’ primary focus is on ILUVIEN. Fluocinolone acetonide intravitreal implant) 0.19 mg. ILUVIEN is an intravitreal implant of fluocinolone acetonide and is the first DME treatment to deliver 36 months of continuous, low-dose corticosteroid therapy with a single injection. Feb 28, 2018. Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results. 2018 A...
Alkermes PLC > Investor Relations > Corporate Overview
Message from the CEO. Q2 2015 Alkermes plc Earnings Conference Call. 160;at 8:30 am ET. 160; 0.54. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Alkermes plc Reports Second Quarter 2015 Financial Results. Alkermes to Host Conference Call to Discuss Second Quarter 2015 Financial Results. Alkermes to Present Data From Late-Stage CNS Portfolio at Upcoming American Society of Clinical Psychopharmacology Annual Meeting. Goldman Sachs and Co. Jefferies and Co., Inc. JPMorgan Securities, Inc. Can I p...
